Strong expression of Nectin-4 is associated with high disease control rate (DCR) (72), and high expression of Nectin-4 in other cancers, including NSCLC, hepatocellular carcinoma, and gastric cancer, has been associated with poor patient outcomes (8, 15, 16). This evidence concerns the gene NECTIN4 and non-small cell lung carcinoma.